WHO ICTRP trial
Activated microglia and alpha 7 nicotinic acetylchorine receptors in…
JPRN-UMIN000038171 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000038171 |
|---|---|
| Public title | Activated microglia and alpha 7 nicotinic acetylchorine receptors in schizophrenia: A PET study (for smoker) |
| Scientific title | Activated microglia and alpha 7 nicotinic acetylchorine receptors in schizophrenia: A PET study (for smoker) - Evaluation for activated microglia and alpha 7 nicotinic receptors using PET in schizophrenia patients (for smoker) |
| Primary sponsor | Hamamatsu University Hospital |
| Secondary sponsors | Hamamatsu Photonics K.K. Hamamatsu Medical Photonics Foundation, Hamamatsu Medical Imaging Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | schizophrenia |
| Interventions | PET, 11C-DPA713 (activated microglia) 5MBq/kg iv PET, 11C-MeQAA (alpha 7 nicotinic receptors) 5MBq/kg iv |
| Registration date | Jul 10, 2019 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: